ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 292 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 1.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $402 | -86.0% | 14,962 | -81.4% | 0.00% | -85.2% |
| Q2 2023 | $2,872 | +614.4% | 80,539 | +408.3% | 0.03% | +440.0% |
| Q1 2023 | $402 | -100.0% | 15,846 | -37.9% | 0.01% | -50.0% |
| Q2 2022 | $898,000 | -56.8% | 25,521 | -23.4% | 0.01% | -23.1% |
| Q3 2021 | $2,078,000 | -38.1% | 33,301 | -17.9% | 0.01% | -58.1% |
| Q2 2021 | $3,357,000 | -33.4% | 40,538 | -38.3% | 0.03% | -69.3% |
| Q4 2020 | $5,037,000 | -73.5% | 65,649 | -78.1% | 0.10% | -87.6% |
| Q4 2019 | $18,984,000 | +6957.2% | 299,297 | +2842.1% | 0.82% | +4700.0% |
| Q2 2019 | $269,000 | -21.3% | 10,173 | -63.1% | 0.02% | -65.3% |
| Q4 2018 | $342,000 | – | 27,593 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |